Chinese clinical guidelines on diagnosis and treatment of lung cancer bone metastasis(version 2024)
Lung cancer is the highest morbidity of malignant tumor in China,and bone metastasis is one of the common sites.With the development of imaging and nuclear medicine technology,the level of early diagnosis of bone metastasis has been improved.There are also many evidence-based evidences and advances in systemic therapy(chemotherapy,targeted therapy,immunotherapy)and bone modification drugs for treatment of bone metastases from lung cancer.The comprehensive treatment model under the guidance of multiple disciplines(including medical oncology,surgery,radiotherapy,interventional medicine,nuclear medicine,psychological rehabilitation,etc.)has been widely implemented in clinical practice.Therefore,Lung Cancer Medical Education Committee of China Medicine Education Association,Youth Specialists Committee of Lung Cancer,Beijing Medical Award Foundation and Lung Cancer Specialty Committee of Chinese Elderly Health Care Association have written the"Chinese Clinical Guidelines on Diagnosis and Treatment of Lung Cancer Bone Metastasis(Version 2024)",based on the"Expert Consensus on Diagnosis and Treatment of Lung Cancer Bone Metastasis(Version 2019)".The aim is to enhance the comprehensive treatment level of lung cancer bone metastasis in China.
万方数据
维普
